ArticleFrontiers in pharmacology2022

ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation.

Dongxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.